Does universal comprehensive insurance encourage unnecessary use? Evidence from Manitoba says "no"

January 2004
CMAJ: Canadian Medical Association Journal;1/20/2004, Vol. 170 Issue 2, p209
Academic Journal
Background: Many argue that "free" medical care leads to unnecessary use of health resources. Evidence suggests that user fees do discourage physician use, at least by those of low socio-economic status. In this study, we compare health care utilization and health among socioeconomic groups to determine whether people of low socioeconomic status see physicians more than would be expected given their health status. Methods: We examined the use of health care services (physicians and hospitals) by residents of Winnipeg, Manitoba, in 1999. The cost of physician services was drawn directly from the claims filed, and the cost of hospital services was estimated using the Case Mix Group and Day Procedure Group methods linked to resource intensity weights and Manitoba hospital costs. We used neighbourhood indicators of socioeconomic status from the 1996 census and measured health status by examining rates of premature mortality, acute myocardial infarction, hip fracture (1995-1999) and diabetes (1999). Using these measures, we compared health status and health care use of residents living in areas with low average household incomes with those living in areas with high average household incomes. All rates were age- and sex-adjusted across the groups. Results: The province spent 44% more providing hospital and physician services to residents of Winnipeg neighbourhoods with the lowest household incomes ($820/person annually v. $596/person for residents of the neighbourhoods with highest household incomes). However, expenditures were strongly related to health status. The 70% of the population on which the province spends 10% of its health care dollars scored well on all health indicators, and the 10% of the...


Related Articles

  • IN BRIEF.  // Occupational Health;Oct2007, Vol. 59 Issue 10, p7 

    The article offers news briefs related to public health in Great Britain. According to a survey, conducted by health insurer HSA, six out of ten Britons are worried they may not be able to afford the cost of health in the future. A study found that screening and treating middle-aged adults with...

  • Cardiovascular risk: a UK priorily it's time to act II.  // Heart;Jun2004 Supplement 4, Vol. 90, piv2 

    Cardiovascular disease is the major cause of premature death and disability in Great Britain, and is a major contributor to the escalating costs of health care. In most cases, atherosclerosis is the underlying pathology. Atherosclerosis develops insidiously over many years and is usually...

  • DIRECT STENTING IN ACUTE MYOCARDIAL INFARCTION (MI) WITH ST SEGMENT ELEVATION. Bernat, I.; Pesek, J.; Bocek, P. // Heart;May2004 Supplement 3, Vol. 90, pA5 

    The article presents a study of direct stenting (DS) in acute myocardial infarction (MI) with ST segment elevation. DS is possible, when the whole lesion is well visible before PCI or after wire recanalisation and when the lesion is not very calcified or very tortuous. In consecutive 335 primary...

  • A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction. Lamotte, Mark; Annemans, Lieven; Kawalec, Pawel; Zoellner, York // PharmacoEconomics;2006, Vol. 24 Issue 8, p783 

    Background: Patients who survive an acute myocardial infarction (MI) are at an Abstract increased risk of subsequent major cardiovascular events and (often sudden) cardiac death. The use of highly concentrated and purified omega-3 polyunsaturated fatty acids (n-3 PUFAs), in addition to standard...

  • Depression increases cardiovascular healthcare costs.  // PharmacoEconomics & Outcomes News;2/7/2009, Issue 571, p8 

    The article discusses research being done on the association of women's depression with their cardiovascular healthcare costs. It references a study by T. Rutledge et al, published in the January 13, 2009 issue of the "Journal of the American College of Cardiology." According to the U.S. study,...

  • Early discharge after primary percutaneous coronary intervention. Laarman, Gerrit J.; Dirksen, Maurits T. // Heart;Apr2010, Vol. 96 Issue 8, p584 

    The length of hospital stay after a successful percutaneous coronary intervention (PCI) for acute myocardial infarction is subject of debate. Patients should not be kept in hospital longer than strictly needed in terms of safety, psycho-social reasons, adequate mobilisation and patient comfort....

  • The Cost of Materials for Intra-Arterial Thrombectomy. BING, F.; JACQUIN, G.; POPPE, A.; ROY, D.; RAYMOND, J.; WEILL, A. // Interventional Neuroradiology;Mar2013, Vol. 19 Issue 1, p83 

    This paper reports the cost of endovascular materials used for the treatment of large-vessel ischemic stroke in the anterior circulation according to the angiographic score and clinical results at three months. From November 2009 to July 2011, 57 ischemic patients (mean age, 64.6 ±13.8 years)...

  • Is Technological Change In Medicine Always Worth It? The Case Of Acute Myocardial Infarction. Skinner, Jonathan S.; Douglas O. Stalger; Fisher, Elliott S. // Health Affairs;2006 Web Exclusives Supplement, Vol. 25, pW34 

    We examine Medicare costs and survival gains for acute myocardial infarction (AMI) during 1986-2002. As David Cutler and Mark McClellan did in earlier work, we find that overall gains in post-AMI survival more than justified the increases in costs during this period. Since 1996, however,...

  • Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients. Hawkes, Anna L.; Atherton, John; Taylor, C. Barr; Scuffham, Paul; Eadie, Kathy; Miller, Nancy Houston; Oldenburg, Brian // BMC Cardiovascular Disorders;2009, Vol. 9, Special section p1 

    Background: Coronary heart disease (CHD) is a significant cause of health and economic burden. Secondary prevention programs play a pivotal role in the treatment and management of those affected by CHD although participation rates are poor due to patient, provider, health system and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics